ADIPOQ and Obesity: Taken together, our results allow us to conclude that the weight loss promoted by BS in female patients with severe obesity presenting or not presenting with MetS could remarkably improve anthropometric, biochemical, and systemic inflammatory variables, especially the ratio of adiponectin to leptin.